TelyRx Holdings Inc.
TELYF
$1.78
-$0.10-5.32%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | ||
|---|---|---|---|---|---|
| Net Income | -263.33% | -12,205.26% | -247.03% | -- | |
| Total Depreciation and Amortization | -23.08% | -28.68% | 515.63% | -- | |
| Total Amortization of Deferred Charges | -- | -- | -26.20% | -- | |
| Total Other Non-Cash Items | 966.43% | 981.12% | -71.75% | -- | |
| Change in Net Operating Assets | -357.77% | 1,545.37% | 607.46% | -- | |
| Cash from Operations | -1,422.42% | -1,090.23% | -14.17% | -- | |
| Capital Expenditure | -58.02% | 76.54% | -79.41% | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -15.41% | 367.78% | 74.91% | -- | |
| Cash from Investing | -27.84% | 250.12% | 31.25% | -- | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -72.73% | -57,731.25% | 39.01% | -- | |
| Issuance of Common Stock | -- | -- | -- | -- | |
| Repurchase of Common Stock | -16,300.00% | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -1,780.00% | 154,625.00% | -40.54% | -- | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -604.90% | 8,553.87% | -50.48% | -- | |